Clinical Trials Insight: 700028303
Latest Information Update: 09 Nov 2007
At a glance
- Drugs GS 6201 (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease; Pulmonary fibrosis; Respiratory tract disorders
- Focus Adverse reactions
- Sponsors CV Therapeutics
Most Recent Events
- 09 Nov 2007 New trial record.